Inventor · disambiguated record
Jesper Haaning
Also filed as: HAANING JESPER · HAANING JESPER M · HAANING JESPER MORTENSEN
8 granted patents·12 pending applications·67 citations·filing 1999–2010
85Inventor score
Files withMAXYGEN HOLDINGS LTD8BAYER HEALTHCARE LLC4BN IMMUNOTHERAPEUTICS INC2HAANING JESPER MORTENSEN2M & E BIOTECH AS2
Top patents by PatentIndex Score
20 records- 0185US7807441B2Methods for therapeutic vaccinationBN IMMUNOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·11 cites·31 claims
- 0284US7700733B2Factor VII or VIIa polypeptide variantsBAYER HEALTHCARE LLC·Filed 2003·Granted Apr 20, 2010·14 cites·17 claims
- 0374US7807638B2Factor V11 or factor V11A GLA domain variantsBAYER HEALTHCARE LLC·Filed 2006·Granted Oct 5, 2010·1 cites·19 claims
- 0469US7771996B2FVII or FVIIa variantsBAYER HEALTHCARE LLC·Filed 2004·Granted Aug 10, 2010·6 cites·18 claims
- 0569US6645500B1Method for down-regulating osteoprotegerin ligand activityM & E BIOTECH AS·Filed 1999·Granted Nov 11, 2003·35 cites·19 claims
- 0660US2006270002A1Factor VII or VIIa Polypeptide VariantsMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 0760US2007117756A1FVII or FVIIa Gla domain variantsMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 0860US2006270000A1Factor VII or VIIa Polypeptide VariantsMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 0960US2006276377A1Factor VII or VIIa Polypeptide VariantsMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 1060US2006270001A1Factor VII or VIIa Polypeptide VariantsMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 1159US2005164932A1FVII or FVIIa Gla domain variantsMAXYGEN HOLDINGS LTD·Filed 2004·Application pending·0 cites
- 1258US2006252128A1FVII OR FVIIa GLA DOMAIN VARIANTSMAXYGEN HOLDINGS LTD·Filed 2006·Application pending·0 cites
- 1356US8987202B2Factor VII or Factor VIIa Gla domain variantsHAANING JESPER MORTENSEN·Filed 2006·Granted Mar 24, 2015·0 cites·31 claims
- 1452US9353365B2Factor VII or VIIa polypeptide variantsHAANING JESPER MORTENSEN·Filed 2010·Granted May 31, 2016·0 cites·21 claims
- 1550US2004115199A1Method for down-regulating osteoprotegerin ligand activityM & E BIOTECH AS·Filed 2003·Application pending·0 cites
- 1649US2009017499A1Rank ligand-binding polypeptidesMAXYGEN HOLDINGS LTD·Filed 2007·Application pending·0 cites
- 1748US7820633B2Methods for therapeutic vaccinationBN IMMUNOTHERAPEUTICS INC·Filed 2003·Granted Oct 26, 2010·0 cites·19 claims
- 1846US2004132971A1Rank ligand-binding polypeptidesFiled 2002·Application pending·0 cites
- 1944US2006166874A1Fvii or fviia variants having increased clotting activityHAANING JESPER M·Filed 2003·Application pending·0 cites
- 2039US2010330669A1Fvii or fviia variantsBAYER HEALTHCARE LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jesper Haaning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →